Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · IEX Real-Time Price · USD
2.390
-0.030 (-1.24%)
At close: Mar 28, 2024, 4:00 PM
2.380
-0.010 (-0.42%)
After-hours: Mar 28, 2024, 7:54 PM EDT
Coherus BioSciences Market Cap
Coherus BioSciences has a market cap or net worth of $275.01 million as of March 28, 2024. Its market cap has decreased by -43.37% in one year.
Market Cap
275.01M
Enterprise Value
635.96M
1-Year Change
-43.37%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $275.01M, a decrease of -31.96%. That is a compound annual growth rate of -4.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 272.80M | 5.25% |
Mar 26, 2024 | 259.20M | 0.86% |
Mar 25, 2024 | 257.00M | -2.13% |
Mar 22, 2024 | 262.60M | -7.18% |
Mar 21, 2024 | 282.90M | 1.22% |
Mar 20, 2024 | 279.50M | 1.19% |
Mar 19, 2024 | 276.20M | 10.39% |
Mar 18, 2024 | 250.20M | - |
Mar 15, 2024 | 250.20M | 3.52% |
Mar 14, 2024 | 241.70M | -5.62% |
Mar 13, 2024 | 256.10M | 2.65% |
Mar 12, 2024 | 249.50M | -1.31% |
Mar 11, 2024 | 252.80M | -5.03% |
Mar 8, 2024 | 266.20M | 8.17% |
Mar 7, 2024 | 246.10M | - |
Mar 6, 2024 | 246.10M | 1.36% |
Mar 5, 2024 | 242.80M | -3.96% |
Mar 4, 2024 | 252.80M | -5.81% |
Mar 1, 2024 | 268.40M | 5.71% |
Feb 29, 2024 | 253.90M | -3.39% |
Feb 28, 2024 | 262.80M | -9.94% |
Feb 27, 2024 | 291.80M | 4.81% |
Feb 26, 2024 | 278.40M | -3.10% |
Feb 23, 2024 | 287.30M | 4.43% |
Feb 22, 2024 | 275.10M | -0.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
FibroGen | 263.72M |
bluebird bio | 262.13M |
Prelude Therapeutics | 260.87M |
Century Therapeutics | 259.92M |
TriSalus Life Sciences | 258.32M |
Werewolf Therapeutics | 256.85M |
OrganiGram Holdings | 255.95M |
uniQure | 255.93M |